🕵️ Cidara Therapeutics, Inc. ($CDTX)
SEC insider & ownership activity, last 12 months · CIK 1610618 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jan 7, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, value withheld pending verification (4 lots) · 1 seller, $2.2M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ward Shane | 0 | – | 1 | $2.2M | Dec 10, 2025 |
| Stein Jeffrey | 4 | value withheld pending verification | 0 | – | Nov 10, 2020 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bong Y. Koh | 9.9% | 13G | May 15, 2025 | filing ↗ | |
| The Vanguard Group | 6.4% | 13G | Jan 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jan 7, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jan 7, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 7, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jan 7, 2026 | filing ↗ |
| Change of control (5.01) | Jan 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 7, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 30, 2025 | filing ↗ |
| Other events (8.01) | Sep 24, 2025 | filing ↗ |